Indian pharma industry 2014-15

1

Indian Pharma Industry

By Balaji Roy

2

How?

Footer Text 3

How?

Footer Text 4

Generic drug development

5

Pharma Value Chain

6

Indian Pharmaceutical Evolution

Phase II

Government Control•Indian Patent Act –1970•Drug prices capped•Local companies begin to make an impact

Phase III Development Phase

•Process development

•Production infrastructure creation

•Export initiatives

Phase IV

Growth Phase

•Rapid expansion of domestic market

•International market development

•Research orientation

Phase V

Innovation and Research•New IP law•Discovery Research •Convergence

1970 1980 1990 2000 2010

Phase I

Early Years•Market share domination by foreign companies•Relative absence of organized Indian companies

7

India Market• India saw its first pharmaceutical company in 1930,

Bengal Chemicals and Pharmaceuticals works

• Till 1970s Indian pharmaceutical market was non existent

• Indian Pharmaceutical market currently stands at approximately 23.6 bn USD**

• 10500 manufacturing units, 3000 pharma companies*

8

Interesting Facts• Branded generics dominate the retail market with

70-80% share

• Price levels and margins are low due to intense competition

• India ranks 10th globally in terms if value, 3rd in terms of volume

• Last 5 years the growth rate is ranging between 13-14% as compared to 9% before that

04/11/2023Footer Text 9

Growth Drivers

04/11/2023Footer Text 10

Growth Predictions

11

Opportunities• As per 'Pharma Vision 2020', the Government of India aims

to make India a global leader in end-to-end drug manufacturing**

• Manufacturing costs in India are approximately 35-40 per cent of those in the US due to low installation and manufacturing costs**

• The biologics market will grow to 3 bn USD by 2020*

• The projected human resource requirement in the Indian pharma sector is estimated to be about 21,50,000 by 2020**

• Industry Least affected by recession

12

Opportunities Contd.• Due to increasing population and income levels, demand for

high-end drugs is expected to reach US$ 8 billion by 2015

• Expenditure on pharmaceuticals is likely to increase to over 40 per cent of the total spending on healthcare by households by 2015 from 28 per cent in 2007

• With 70 per cent of India's population residing in rural markets, various pharma companies are investing in the distribution network in rural areas

• Increased penetration of chemists, especially in the rural parts of the country would make OTC drugs easily available

13

Current Top Players - India

14

US Contribution

15

US Generics Market share

16

Indian impact in US

17

Indian Pharma in Speciality products

18

ANDA pipeline

04/11/2023Footer Text 19

US Acquisitions

20

USFDA Issues

21

Country wise Import alerts

22

Factor wise comparison

23

Factor wise comparison

24

Factor wise comparison

25

Thank You!